Literature DB >> 2649820

The reliability and predictive value of an amniotic fluid scoring system in severe second-trimester oligohydramnios.

T R Moore1, J Longo, G R Leopold, G Casola, B B Gosink.   

Abstract

Sixty-two cases of oligohydramnios diagnosed by ultrasound between 13-28 weeks' gestation were reviewed. Three experienced ultrasonographers used a subjective scale to rate the oligohydramnios as mild, moderate, severe, or anhydramniotic. Interobserver reliability was excellent (intraclass correlation coefficient 0.81). The overall perinatal mortality rate was 43%, and the incidence of pulmonary hypoplasia was 33%. One-third had lethal congenital anomalies. The frequency of adverse outcome correlated strongly with the most severe degrees of oligohydramnios; 88% of the fetuses with severe oligohydramnios or anhydramnios had lethal outcomes, compared with 11% in the mild/moderate group. The presence of an anuric urinary tract anomaly was associated with the most severe grades of oligohydramnios and was uniformly fatal. Pulmonary hypoplasia was diagnosed in 60% of the severe group versus 6% in the moderate group. We conclude that subjective grading of oligohydramnios by experienced observers is both reliable and predictive of outcome. The finding of severe oligohydramnios in the second trimester is highly predictive of poor fetal outcome and should stimulate a thorough search for etiology and consideration of intervention. Moderate grades of reduced amniotic fluid may be managed with relative optimism.

Entities:  

Mesh:

Year:  1989        PMID: 2649820

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Heparin successfully improved an early onset intrauterine growth restriction accompanied by severe oligohydramnios.

Authors:  Hong-Nü Chu
Journal:  Int J Gen Med       Date:  2008-11-30

2.  Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.

Authors:  Sarah Rebecca Porter; Guy Czaplicki; Jacques Mainil; Raphaël Guattéo; Claude Saegerman
Journal:  Int J Microbiol       Date:  2011-12-13

3.  Treating oligohydramnios with extract of Salvia miltiorrhiza: A randomized control trial.

Authors:  Hong-Nü Chu; Mei-Juan Shen
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.